Detalles de la búsqueda
1.
Sodium-glucose co-transporter 2 inhibitor therapy reduces the administration frequency of anti-vascular endothelial growth factor agents in patients with diabetic macular oedema with a history of anti-vascular endothelial growth factor agent use: A cohort study using the Japanese health insurance claims database.
Diabetes Obes Metab
; 26(4): 1510-1518, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240052
2.
Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke.
BMC Med
; 19(1): 131, 2021 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34103026
3.
R3hdml regulates satellite cell proliferation and differentiation.
EMBO Rep
; 20(11): e47957, 2019 11 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31524320
4.
Febuxostat does not delay progression of carotid atherosclerosis in patients with asymptomatic hyperuricemia: A randomized, controlled trial.
PLoS Med
; 17(4): e1003095, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32320401
5.
Primary adrenal insufficiency due to lymphomatoid granulomatosis in a 32-year-old man.
Lancet
; 403(10442): e33, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38823995
6.
Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study).
Diabetes Obes Metab
; 21(8): 1990-1995, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30993861
7.
Urinary α1 microglobulin level is useful for selecting sodium-glucose transporter 2 inhibitor or metformin for visceral fat reduction in patients with type 2 diabetes.
Diabetes Obes Metab
; 25(10): 3071-3075, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37385959
8.
Imeglimin-mediated glycemic control in maternally inherited deafness and diabetes.
J Diabetes Investig
; 14(12): 1419-1422, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37715448
9.
Metabolomic analysis of serum samples from a clinical study on ipragliflozin and metformin treatment in Japanese patients with type 2 diabetes: Exploring human metabolites associated with visceral fat reduction.
Pharmacotherapy
; 43(12): 1317-1326, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37772313
10.
Predictive model and risk engine web application for surgical site infection risk in perioperative patients with type 2 diabetes.
Diabetol Int
; 13(4): 657-664, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36117930
11.
Sodium-Glucose Co-Transporter 2 Inhibitors Reduce Macular Edema in Patients with Diabetes mellitus.
Life (Basel)
; 12(5)2022 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35629361
12.
Cyclothymic Temperament is Associated with Poor Medication Adherence and Disordered Eating in Type 2 Diabetes Patients: A Case-Control Study.
Diabetes Ther
; 12(9): 2611-2624, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34331669
13.
Assessing Patient Satisfaction Following Sodium Glucose Co-Transporter 2 Inhibitor Treatment for Type 1 Diabetes Mellitus: A Prospective Study in Japan.
Diabetes Ther
; 12(1): 453-460, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33237553
14.
Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities: Single-Arm, Exploratory Trial.
Diabetes Ther
; 12(5): 1415-1427, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33738773
15.
Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study.
Diabetes Ther
; 12(1): 183-196, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33098565
16.
Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME-V study).
J Diabetes Investig
; 12(2): 200-206, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32623839
17.
Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema.
Case Rep Ophthalmol Med
; 2020: 8867079, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33274092
18.
Safety and Efficacy of Ranibizumab and Luseogliflozin Combination Therapy in Patients with Diabetic Macular Edema: Protocol for a Multicenter, Open-Label Randomized Controlled Trial.
Diabetes Ther
; 11(8): 1891-1905, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32542431
19.
Immune-mediated acquired lecithin-cholesterol acyltransferase deficiency: A case report and literature review.
J Clin Lipidol
; 12(4): 888-897.e2, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29937398
20.
Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarction.
Oncotarget
; 9(5): 5600-5613, 2018 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-29464021